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Abstract. Historic levels of funding have reduced the global burden of malaria in recent years. Questions remain,
however, as to whether scaling up interventions, in parallel with economic growth, has made malaria elimination more
likely today than previously. The consequences of “trying but failing” to eliminate malaria are also uncertain. Reduced
malaria exposure decreases the acquisition of semi-immunity during childhood, a necessary phase of the immunological
transition that occurs on the pathway tomalaria elimination. During this transitional period, the risk of malaria resurgence
increases as proportionately more individuals across all age-groups are less able to manage infections by immune
response alone. We developed a robust model that integrates the effects of malaria transmission, demography, and
macroeconomics in the context of Plasmodium falciparummalaria within a hyperendemic environment. We analyzed the
potential for existing interventions, alongside economic development, to achieve malaria elimination. Simulation results
indicate that a 2% increase in future economic growth will increase the US$5.1 billion cumulative economic burden of
malaria in Ghana to US$7.2 billion, although increasing regional insecticide-treated net coverage rates by 25%will lower
malaria reproduction numbersby just 9%, reducepopulation-widemorbidity by−0.1%, and reduceprevalence from54%
to 46% by 2034. As scaling up current malaria control tools, combined with economic growth, will be insufficient to
interrupt malaria transmission in Ghana, high levels of malaria control should be maintained and investment in research
and development should be increased tomaintain the gains of the past decade and tominimize the risk of resurgence, as
transmission drops.
INTRODUCTION
Malaria was responsible for an estimated 435,000 deaths
worldwide in 2017.1 This is a public health tragedy by any
measure, but it does represent a decline of 50%since 2000.1,2
Progress has been attributed primarily to increasing the cov-
erage of malaria control interventions. However, malaria is
affected by many complex and interrelated factors and, al-
though it is believed that urbanization and economic devel-
opmentmay also have played a role,2 the size of this influence
and their potential contribution toward the goal of elimination
is unknown. In 2007, Bill andMelindaGates, joined by the then
director general of the WHO, Margaret Chan, declared that
malaria eradication was possible and should be an in-
ternational goal,3 one which has since been pursued by the
malaria community.4 However, malaria eradication is not new
terrain. Many previous efforts have been confounded and
have led to calls for malaria elimination programs to establish
links across research disciplines beyond epidemiology to in-
clude expertise on economic activities and population
movements.5
The WHO’s Global Malaria Eradication Programme oper-
ated from 1955 to 1969 and relied heavily on dichlorodiphenyl-
trichloroethane to interrupt transmission, ultimately failing to
rid malaria from high-transmission settings as partial suc-
cess was commonly followed by resurgence. Cohen et al.6
identified 75 instances of failed attempts to eliminatemalaria
in 61 countries since the 1930s, attributable tomultiple factors
including the diversion of domestic and external resources
away from malaria elimination efforts, as well as 19 cases in
which changes in land use for commercial purposes con-
tributed to resurgence. When the Global Malaria Eradication
Programme was officially suspended, national malaria pro-
grams in Africa and Asia were largely left with compromised
capacity for malaria control because of years of singular fo-
cus onmalaria eradication. Then, during the global economic
crises of the early 1970s, malaria-endemic countries adop-
ted policies to stimulate economic growth that included
aggressive encroachment into forested lands for commercial
enterprise. These economic incentives resulted in pop-
ulation movement, increasing exposure to vectors carrying
malaria and triggering an epidemic resurgence. As a result,
private demand for preventive and curative use of chloro-
quine increased, driving drug pressure on natural selection
that accelerated chloroquine resistance. This completed a
cascade of adverse consequences that resulted from having
neglected malaria control strategies after concerted elimi-
nation efforts, a sequence of events that had a significant
influence on public and private demands for malaria inter-
ventions, population demographics, and the epidemiology of
malaria.5 Present-day malaria control efforts may be reach-
ing a critical juncture which is not so different from the past.7
Recent years have witnessed remarkable levels of fund-
ing for Africa from national and international sources to
combat malaria; annual funding more than doubled from
US$1.3 billion in 2005 toUS$3.1 billion in 2017.1 However, it
was estimated that global investment in malaria control and
elimination by governments ofmalaria-endemic countries and
international partnersdecreased toUS$2.7billion in 2018,well
short of the US$5.0 billion required to meet the elimination
targets set by the Global Technical Strategy for Malaria.8 In
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addition, recent reports indicate that progress toward elimi-
nation may have stalled and the burden of malaria in some
countries may even be returning to 2010 levels.7 In light of this
evidence, questions must be answered. Is the chance of
elimination higher today than previous attempts? If so, what is
different now? Are recent studies correct that using long-
lasting insecticide-treated nets (ITNs) in combination with in-
door residual sprayingmaynot, by themselves, be sufficient to
eliminate malaria?9 Or are there indirect factors which, if
captured in parallel with malaria interventions, make elimina-
tion with existing tools more feasible? For example, questions
remain concerning the role that broader influences of eco-
nomic activities, population demographics, and private de-
mand for interventions might play in current elimination
strategies. Can malaria elimination be achieved directly by
continuing to scale up the use of existing interventions, such
as ITNs, to achievegreater population coverage, and indirectly
by economic growth? Alternatively, if current efforts to reduce
malaria transmission fall short of elimination, and if the recent
reduction in research and development funding for malaria
vaccines and drugs continues,1 might the decrease in acqui-
sition of semi-immunity against malaria, at the population
level, from years of intensified control, produce a tinderbox of
risk that translates into a demographic shift of disease that will
afflict all ages?
In the absence of a silver bullet to accomplish elimination,
answering these questions is important and should be priori-
tized to guide the design of optimum control and elimination
strategies. However, at this pivotal point for investment where
funding for malaria interventions worldwide has plateaued,8
and when some model estimates from 2014 to 2016 show an
increase in the number of malaria cases in more than 70% of
the high-burden countries where per capita funding for the
population at risk had previously reduced,7 finding answers to
the important policy questions highlighted earlier is as urgent
as it is complex. Assessing the potential of economic growth
or scaling up the use and coverage of existing interventions to
achieve malaria elimination first requires understanding the
interaction and feedback loops5 between epidemiology, de-
mography, and economics to enable development of models
or tools that can quantify this potential. These models must
capture multiple perspectives and simultaneously include
spillover and feedback effects which may enhance or con-
found intervention efforts.
Many of the multiple factors which affect progress toward
malaria elimination interact with each other, and some are
exogenous to intervention strategies. For example, there is
strong evidence that Plasmodium falciparum (Pf) malaria sig-
nificantly impacts economic development and growth.10,11
However, economic development may also affect R0 (the
expected number of secondary infections produced by each
infected human in the absence of control or acquired immu-
nity)12,13 asdevelopment-induceddemographic changesmay
result in reduced human–vector contact.14,15 Therefore, cap-
turing this bidirectional relationship in a model requires a
specification of feedback between model components.
Research also indicates that economic growth could
stimulate private demand for ITNs and be an external driver for
reductions in the controlled reproductive number, RC (which
accounts for thepresenceof interventions).16However, evidence
to quantify the strength of interaction between growth and ITN
uptake is lacking. The impact of economic development on
malaria transmission is determined by “private” behavior, that
is, the reaction of households to income growth, including
internal migration (rural to urban) and the personal uptake of
malaria interventions that are distinct from malaria control
measures delivered through public channels. Capturing these
connections is, therefore, important for policy analysis.
Studying the effect of these interactions is as complex as it
is important, and the bar to this kind of cross-disciplinary
policy analysis has previously been the technical difficulty
of integrating models which simultaneously capture all of
these elements together with their dynamic feedback ef-
fects. However, previous applications of computable gen-
eral equilibrium (CGE) models in the context of HIV/AIDS,17
health co-benefits of GHD reduction strategies,18 and di-
etary change19–21 have advanced the level of complexity and
use of these models in a health context, and the tool we
developed for this study demonstrates that full integration of
models is possible. Furthermore, its utility is illustrated in
analyses of various scenarios for future economic growth
and scaling up of interventions. Details underlying our ana-
lytical tool, including the setup of this tool for the current
application toPfmalaria data fromGhana, are publicly available
elsewhere.22
We capture the potential public health consequences of
failing to eliminate malaria after having intensified control ef-
forts to historic levels, and by analyzing changes in future
economic growth and scaling up of interventions, our study
provides a means to measure the feasibility of the Ghana
Health Service Resource Mobilization plan’s ultimate goal to
achieve “self-sufficiency in funding of malaria elimination by
2030.”
As illustrated in Figure 1, we use our integrated model, with
its regional epidemiological models of malaria transmission
and demographic models embedded as sub-models within a
society-wide macroeconomic framework, to perform analy-
ses of both endogenous private behavior and exogenous
public interventions. We model the full circular impacts of
income-driven populationmovement andmalaria intervention
adoption on regional economic and epidemiological out-
comes including changes in RC. For the epidemiological
component, we replicated the Swiss Tropical Institute (STI)
malaria model for a typical sub-Saharan African nation,
Ghana,23 with hyperendemic transmission. The results pre-
sented in the following use this model to determine the po-
tential for existing interventions, alongside economic
development, to achieve malaria elimination in Ghana.
MATERIALS AND METHODS
Macroeconomicmodel. The policy tool at the heart of this
analysis, which has been developed to perform integrated
assessment, is a CGE model, specifically the IFPRI standard
CGE model.24 The sectoral macroeconomic model captures
the cost-minimizing and profit-maximizing behavior of pro-
ducers, the consumption and saving behavior of households
and government, taxation mechanisms and the use of labor,
capital, and other factors to produce goods and services for
investment, consumption, and trade. The specification of the
production behavior enables health-related labor changes,
across all sectors, to be captured and valued at a dynamic
wage level which adjusts endogenously according to eco-
nomic growth. The social accounting matrix (SAM) is themain
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database used to calibrate the CGE model and was based on
the 2004 Ghana SAM which relies on the most recent core
Supply–Use Table data.25 A dynamic simulation was used
to target 2005–2014macroeconomic indicators and establish
2014 as the new base year, and the counterfactual (baseline)
20 year growthpath, for 2015–2034,wasconstructed to target
2006–2010 historical Ghana growth rates for nominal
GDP (25.4% per annum [p.a.]) and real GDP (6.6% p.a.).22
The counterfactual growth rates and the implied GDP defla-
tor (which grows at 17.4% p.a.) also match recent
experience.26,27 The relevance of the CGE method, with its
recursive dynamic, multi-sector, household-level modeling
approach, and its potential to capture productive labor supply
impacts to estimate disease burdens have been highlighted,
previously, by the WHO.28 The base model has been signifi-
cantly developed to form a fully integrated macroeconomic,
epidemiological, demographic model framework, the techni-
cal aspects of which are fully documented and reported
elsewhere.17 Those elements of the model which are of pri-
mary relevance to the analyses in this article are briefly out-
lined in the following subsections.
Measurement and context. Our integrated model frame-
work is generalizable, but country contexts vary in terms of
their potential for the achievement of elimination and the
barriers to elimination. Currently, malaria elimination strate-
gies are being pursued in several African nations, most of
which have geographical barriers to reintroduction and/or
climatic conditions favoring elimination strategies; for exam-
ple, Botswana, Comoros, Namibia, South Africa, and Swazi-
land.29 Our study focuses on the less favorable elimination
context of Ghana which captures seasonality and takes a
more nuanced approach to malaria transmission dynamics.
However, the selection of Ghana as the country context fur-
ther highlights the importance of our subregional analysis.
Sub-country analysis. Measurement of the effectiveness
of malaria control has most recently focused on a statistically
significant association between expanded coverage of pre-
vention measures and reductions in Pf malaria prevalence in
the 2- to 10-year-old reference age-group (PfPR2–10) across
Africa.10 However, the strength of the link is disputed.9 Fur-
thermore, when modeling malaria elimination, capturing low/
high areas of transmission, at the sub-country level, is im-
portant. Thus, our integrated model uses 19 regional malaria
transmissionmodels including theGreater AccraMetropolitan
Area and 18 other regions which are disaggregated by eco-
logical zone (coastal, forest, and savannah); rural and urban
locations; and low–, medium–, and high–malaria transmission
locations. This regional division applies not only to the in-
tegrated epidemiological malaria transmission models and
demographic population models but also to the representa-
tive households in the multi-sector CGE model which were
derived from disaggregation of households in the underlying
SAM data set based on consumption shares from the 2005/
2006 GLSS5 household survey.30
Integrating demographics and epidemiology. The de-
mographic sub-module captures annual population progres-
sion for 1-year age-groups at the regional level. It is based on
UN population projections, which were regionalized, tomatch
our 19 household categories, using population shares from
the 2005/2006 GLSS5 household survey.30 Migration be-
tween regions is also specified in our integrated demographic
model and is based on census data.
Each of our regional epidemiological sub-models are a re-
specification of a continuous-time epidemiological model as a
biweekly discrete timemodel,which allows for integrationwith
our annually recursive regional demographic and macroeco-
nomic sub-models. The regional models, which, in the Mac-
Donald Ross tradition, use two compartments of human and
vector populations,31 were extended to account for human
superinfections32 and calibrated using region-specific human
prevalence rates and entomological inoculation rates (EIRs)
(the key biomarker for malaria transmission intensities), de-
rived from the Malaria Atlas Project database.33 Remaining
parameter valueswere derived from the literature.34–36Clinical
outcomes, within the integrated model, were calculated, en-
dogenously, based on lookup tables derived from the STI
model.23 The STImodel includes an age-specific link between
clinical outcomes and EIRs, and this allows the model to also
FIGURE 1. Diagram of epidemiological demographic macroeconomic malaria model framework and feedback effects between the macro-
economy and regional sub-models. This figure appears in color at www.ajtmh.org.
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capture the relationship between transmission intensity and
immunologic stimulation or “semi-immunity.” These nonlinear
features of the relation between transmission intensity and
clinical outcomes, embodied in the underlying STI model, are
also captured in our model framework via a set of piecewise
linear specifications, based on the aforementioned simulated
lookup tables from the STI model. Surface figures of the
lookup tables for morbidity and excess mortality associated
with P. falciparum infection are provided in Figure 2A and B,
respectively, for 12-month all-year transmission. The surface
plots show the non-linear relationship between transmission
intensity, measured by log-transformed EIRs (log EIRs), and
clinical health outcomes (morbidity and mortality) resulting
from semi-immunity. The plot indicates that as transmission
intensity falls, morbidity and mortality fall among children, but
a swell emerges for middle and older age-groups. More detail
on the technical specification of the model framework and its
sub-components and tables of parameter estimates are
available in the full documentation article.17
Capturing private behavior. A key issue, which has been
outlined previously as important for the assessment of growth
and scaling up of interventions, is the need for separation, and
separate modeling, of private behavior and exogenous policy
shocks. Incentive-based private behavior is important for
policy analysis and includes rural–urban migration between
high- and low-prevalence regions, and adoption of malaria
interventions, such as artemisinin-based combination thera-
pies and ITNs. Household decisions closely correlate with the
expected income levels. Although they are critical to the im-
pact of economic development on malaria elimination, the
combined effects of these income-based incentives have not
been studied previously.
Prior evidence on individual mechanisms, by themselves,
suggests that economic incentives could play a role inmalaria
control and elimination.37,38 Our integrated framework ad-
dresses the combined picture by allowing economic incen-
tives from the macroeconomic CGE sub-model to affect both
regional demographic sub-models (through migration incen-
tives), regional Pf epidemiological sub-models (through pri-
vate interventiondemands for ITNs), and regional labormarket
morbidity impacts (through private demand for artemisinin-
based combination therapies). These impacts, subsequently,
combine to produce predictions of labor force impacts and
pecuniary intervention costs which feed back into the mac-
roeconomic model. Because these endogenous feedback
effects are specified, separately, for each of our 19 regional
household types, the model allows for intervention strategies
to have region-specific impacts and enables economy-wide
disease burden assessments to account for regional variation
in transmission intensities and clinical outcomes as presented
earlier. Further technical details on the implementation of
these methods are presented elsewhere.17
Estimating disease burden. To measure the potential fu-
ture twin health and economic burdens of malaria and assess
the potential future benefits of control and elimination efforts,
we simulated health and macroeconomic burdens which
could be averted over the two coming decades if elimination
was achieved in the base year. Themethod to accomplish this
involved running policy scenarios, under the assumption that
malaria prevalence/transmission is zero over our 20-year time
horizon (2015–2034), and comparing the impacts to our
baseline counterfactual growth scenario, based on counter-
factual malaria prevalence/transmission patterns. Further
details of this methodology are provided elsewhere.39
Modeling scenario: economic growth. The integrated
nature of ourmodel, where changes in household incomemay
provoke migration and changes in private demand for inter-
ventions, is the critical feature which allows us to analyze the
impact of changes in economic growth on epidemiological,
demographic, and clinical health outcomes, and thereby to
study whether, and to what extent, economic growth can
assist in controlling, and ultimately eliminating, malaria. Spe-
cifically, we simulate variations in economic growth rates,
ranging between ±2 percentage points per annum and cen-
tered around the 6.6% baseline growth rate.
Modeling scenario: scaling up ITNs. In the same way as
earlier, our integrated model framework, with its separation,
and separate modeling, of private behavior and exogenous
policy shocks, allows us to analyze the impact of changes in
public scaling up of preventive interventions on epidemio-
logical, demographic, and clinical health outcomes, and
thereby to study whether, and to what extent, such scaling up
can assist in controlling, and ultimately eliminating, malaria.
Specifically, we simulate the scaling up of ITN coverage rates
by up to 25 percentage points relative to counterfactual levels.
Sensitivity analysis. Computable general equilibrium
models are deterministic and are calibrated with economic
data which are not statistically estimated. As a consequence,
sensitivity analyses are used, extensively, to test key as-
sumptions. In our case, a key assumption relates to the uptake
of ITNs, which are used to determine effective coverage rates
in the model. Documentation of uptake and coverage rates is
provided in the documentation paper22 and tabulated in the
Supplemental Materials. To test the sensitivity of our model to
FIGURE 2. (A) Malaria morbidity (uncomplicated episodes per per-
son) by 5-year age-group and log entomological inoculation rate (EIR)
transmission intensity. (B) Malariamortality rates by 5-year age-group
and log (EIR) transmission intensity. This figure appears in color at
www.ajtmh.org.
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FIGURE 3. 2015–2034 Malaria disease burdens in Ghana: The impact of economic development. (A) Change in NPV GDP (billion US$; 2014
prices). (B) Macroeconomic share (% of NPVGDP). (C) Change in NPVGDP per capita (US$; 2014 prices). (D) Macroeconomic share (%NPVGDP
per capita). (E) Cumulatedmortality (1,000deaths). (F) Excessmortality rates (percent/person/year). (G) Cumulatedmorbidity (millionuncomplicated
episodes). (H) Excess morbidity rates (episodes/person/year). ΔNPV GDP = change in net present value of GDP (accounting for the future value of
money);%ofNPVGDP=percentage of net present value ofGDP (accounting for the future valueofmoney); p.a. = per annum.This figure appears in
color at www.ajtmh.org.
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changes in uptake rates, we ran simulations for low uptake (by
halving uptake rates for all regional households) and high
uptake (by doubling uptake rates for all regional households).
RESULTS
To express the cumulative macroeconomic burden of
malaria as a time value of future GDP, we apply a 5.0% real
discount rate to future 2015–2034 macroeconomic burden
estimates and sum them. This valuation is labeled as net
present value (NPV). The baseline changes in NPV of GDP (or
“NPV GDP”), due to the elimination of the malaria disease
burden, is presented in Figure 3A in billion US$, whereas the
relative impacts, as a percentage of baseline total NPV GDP,
are presented in Figure 3B. These results show that if Ghana
continues along its current economic growth path over the
coming 20 years, the cumulative macroeconomic burden of
malaria will amount toUS$5.1 billion (in 2014 prices) or around
0.5% of the NPV of future GDP. Without additional public
action, such as increased domestic use of ITNs, the cumula-
tive health burdenwill include an estimated 43,400 deaths and
123.4 million uncomplicated malaria episodes.39
Because our integrated CGE model captures true pro-
ductivity losses and spillover effects, valued at dynamic wage
rates, these results cannot be readily compared with alterna-
tive valuation methodologies, and CGE studies of malaria are
rare. However, for comparison, there is one CGE modeling
study, which excludes health modeling, but which has,
nonetheless, been used to estimate hypothetical malaria in-
tervention effects in Ghana.40 The latter study shows that a
hypothetical treatment of children with 100% coverage, 50%
efficacy against clinical malaria, and 20% efficacy against
malaria mortality might yield economic gains of US$6.93
billion or 0.5% in 30 years. The results after 20 years estimated
a GDP gain of approximately 0.3%, which is approximately
half our estimates of the macroeconomic disease burden.
More detailed analyses on disease burdens, using our in-
tegrated methodology, have, as noted previously, been con-
ducted and are available elsewhere.39
Linkages between malaria and economic growth. Eco-
nomic growth is strongly correlated with the health burden
frommalaria, which is expected given the importance of labor
to the economy. However, contrary to popular belief, the
correlation is positive: reduced future economic growth low-
ers the cumulative economic burden frommalaria by asmuch
as one-third from US$5.1 billion to US$3.4 billion (Figure 3A),
whereas increased economic growth could significantly in-
crease the economic burden to US$7.2 billion. This is attrib-
utable to wage effects: one of the strengths of CGE modeling
is its ability to capture dynamic changes inwages, over time, in
response to changes in the economy, and in our integrated
model framework, this manifests itself in our ability to un-
dertake model-consistent valuation of workforce reductions
attributable to future changes in malaria disease burdens.
Wage levels generally increase with economic growth be-
cause of highermarginal returns to labor, and the loss of labor,
attributable to malaria, therefore carry a larger value in
a growing economy. Economic growth also increases
prevention-related demand for ITNs, which, in turn, affects
morbidity and mortality. However, the health-related changes
in workforce participation rates, which stem from increased
demand for and use of ITNs, are not sufficiently large to
counter the dominating wage impact on the macroeconomic
burden. Results from our simulations, presented in Figure 3,
show mortality impacts as the number of deaths (Figure 3E),
morbidity impacts as the number of uncomplicated episodes
FIGURE 4. 2015–2034 Malaria reproduction numbers in Ghana: The impact of economic development and private incentive channels. (A) R0
(basic reproduction number) (2034 levels). (B) ΔRC (private migration channel) (2015–2034; percentage points). (C) Change in RC (total change)
(2015–2034; percentage points). (D) ΔRC (private ITN demand channel) (2015–2034; percentage points) (counterfactual: no private migration).R0 =
reproductive number; ΔRC = change in controlled reproductive number; p.a. = per annum. This figure appears in color at www.ajtmh.org.
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(Figure 3G), and morbidity and mortality rates per person per
year (Figure 3F and H). These results indicate that increased
economic growth only marginally affects clinical outcomes,
including child mortality (−2%) and adult mortality (+2%).
The counter-intuitive impact on adult mortality is attributable
to interaction effects of economic growth. As mentioned
earlier, higher economic growth increases wages and pro-
vokes increased uptake of ITNs, and this has a positive health
impact on younger population members by reducing expo-
sure before adulthood. However, lower exposure among
younger population members prevents the acquisition of
semi-immunity, something which is only acquired after ex-
posure to the parasite. Thus, decreased transmission that fails
to achieve elimination will produce a demographic shift which
may result in increased mortality among adults whose lower
exposure to malaria as children has prevented them from
acquiring semi-immunity and left them more susceptible to
the clinical effects of malaria in adulthood, a phenomenon
which has been previously proposed but not quantified.41
Because our model estimates that increased economic
growth increases the economic NPV GDP disease burden
more than it increases the population (due to higher marginal
productivity of diseased workers), it is not surprising that
measurements of economic disease burden, expressed as
NPV GDP per capita and shown in US$ per capita, in
Figure 3C, and in relative terms, in Figure 3D, also increase.
Our baseline estimate of the NPV GDP per capita measure of
disease burden is US$6.1 (0.4% of GDP per capita), but
increasing/decreasing growth by 2 percentage points yields
estimates of US$8.8 (0.5%)/US$3.8 (0.3%), respectively, in-
dicating that the counter-intuitive effects of economic growth,
on the economic burden of malaria, will be felt at both the
national and individual levels. The ripple effects of economic
development are, therefore, likely to represent a set of policy
challenges for both economic and health authorities in hy-
perendemic countries such as Ghana.
Overall, integrated modeling suggests that economic
development is a weak tool for malaria control. Future
reproduction numbers R0 will be relatively unaffected
(Figure 4A), and although controlled reproduction numbersRC
will declinemoderately in rural areas by up to 8.5%because of
increased urbanization in the high growth scenario, they will
be relatively unaffected elsewhere (Figure 4C). Without addi-
tional intervention, regionalRC valueswould, therefore, remain
high over the next 20 years for all regions of Ghana (RC 
35–55 on average; RC > 12 for all subregions; see Figure 5),
regardless of whether economic growth improves or deterio-
rates. Economic growth also has some impact on malaria
prevalence: our simulatedcountrywideprevalence estimateof
56.9% in 2015 decreases to 54.1% by 2034 in the baseline
scenario (not shown). However, our lower (−2%) growth sce-
nario results in a smaller reduction to 55.8%by 2034, whereas
our upper (+2%) growth scenario reduces prevalence to
51.7%by 2034. Our results suggest, therefore, that economic
development cannot be relied on to achieve external malaria
elimination. To impact positively on malaria elimination,
FIGURE5. Economicdevelopment impactoncontrolled regional reproductionnumbers (change inRC).GAMA=GreaterAccraMetropolitanArea;
RC = controlled reproductive number; p.a. = per annum. This figure appears in color at www.ajtmh.org.
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economic growth must produce sufficiently strong incentives
on individual behavior to invokeawillingness topurchase ITNs
(Figure 4B) and to migrate from high- to low-transmission
areas (Figure 4D). Although growing income levels will raise
private ITN demand and outward immigration will further in-
crease effective ITN coverage rates for the remaining rural
population, the direction of migration patterns will also put
pressure on urban areas.
Impact of scalingup ITNs.Because economic growthmay
have a limited, if not negative, effect on the elimination of
malaria, what about the role of external public preventive in-
terventions such as public procurement of ITNs? Although
some research has suggested that malaria control and elimi-
nation in Africa can be achieved by mass procurement
and distribution of ITNs,10 the scale of predicted reductions
in malaria transmission intensities at the regional level are
not supported by our structural modeling for Ghana. Our re-
sults suggest that a future public campaign to increase re-
gional ITN coverage rates by 25 percentage points will lower
malaria reproduction numbers by at most 9% (Figure 6F).
This reduction in reproduction numbers is accompanied
by a cumulative reduction in morbidity of 2.83 million epi-
sodes (0.035%), among children, and 5.31 million epi-
sodes (0.012%), in total, over our 20-year simulation period
(Figure 6C and D). In terms of prevalence, our simulations
suggest that scaling up ITN coverage by 25% will reduce
malaria prevalence, from 54.1% to 45.9%, in 2034 (not
shown), but will not, by itself, bring elimination within reach.
However, on the economic side, our structural analysis
further suggests that increasing coverage of ITNs will be ex-
pensive and, unless the large (and recurring) costs of such
campaigns are funded by external partners, the increased
economic burden of scaleup could amount to US$1.6 billion
(in 2014 prices) or around 0.2% of the future NPV GDP
(Figure 7A and B). Furthermore, if public ITN distribution
campaigns were used to increase ITN coverage, our analysis
predicts (partially) adverse effects on child and adult mortality,
similar to growth-driven private ITN demand (Figure 6B).
Whereas excess mortality rates may decline by 0.0026 per-
centage points, for children younger than 5 years, by 2034, the
reduced semi-immunity, carried into adulthood, could in-
crease adult excess mortality rates by 0.0002 percentage
points (Figure 6B). The expense of scaling up interventions is
also reflected in NPVGDPper capita estimates (Figure 7C and
D). Although scaling up of ITN coverage rates, by 25 per-
centage points, has a positive population-wide impact on
mortality (reducing child deaths by 2,078 and increasing adult
deaths by 726), the overall effect on NPV GDP per capita is a
reduction of US$2.0, or 0.1%, and our results suggest that
these impacts are approximately linear such that for every 5%
increase in ITN coverage, GDP per capita will decline by
US$0.4.
Sensitivity analyses. Sensitivity analyses of our growth
and ITN scaling up scenarios, for low (half) and high (double)
ITN uptake rates, are shown in Figure 8A–D. The results in-
dicate that doubling uptake rates reducesNPVGDPestimates
of disease burdens by approximately 3% for all growth sce-
narios and halving uptake rates increasesNPVGDPestimates
of disease burden by approximately 1%.
Applying a similar set of sensitivity analyses to our ITN
scaling up scenarios reveals, not surprisingly, that as the
provision of ITNs increases, the effect of varying uptake rates
also increases. Although halving/doubling uptake rates
causes −3%/+1% variations in NPVGDP burden estimates at
baseline coverage rates, it causes −14%/+9% impacts on
GDP burden estimates for the scenario where ITN coverage is
FIGURE 6. 2015–2034 Public action: ITN scaling up (morbidity, mortality, and control). (A) Insecticide-treated net scaleup to change in cumulated
mortality (1,000deaths). (B) Insecticide-treated net scaleup to change in excessmortality (excessmortality/person/year). (C) Insecticide-treated net
scaleup to change in cumulated morbidity (million uncomplicated episodes). (D) Insecticide-treated net scaleup to change in morbidity rates
(episodes/person/year). (E) Insecticide-treated net scaleup to RC (2034). (F) Insecticide-treated net scaleup to change in RC (percentage points)
(2014–2034). ITN = insecticide-treated net; R0 = reproductive number; RC = controlled reproductive number. This figure appears in color at
www.ajtmh.org.
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increased by 25 percentage points. Relative variations in NPV
GDP per capita are similar to the changes in NPV GDP, in-
dicating that sensitivity to variations in uptake rates is similar at
the national and individual levels. The economic disease
burden impacts of the aforementioned sensitivity scenarios
are tabulated in the Supplemental Materials.
CONCLUSION
Our structural modeling for Ghana, which accounts for
both epidemiological and demographic interactions, sug-
gests that neither economic development nor public ITN
scaling up efforts alone will be sufficient to eliminate malaria.
Our analysis further suggests that private incentive mecha-
nisms, in the form of internal migration and private ITN de-
mand, which affect RC rather than R0, will lower reproduction
numbers by less than 6% over the coming 20 years, and
public ITN distribution campaigns will have a similar limited
capacity to interrupt malaria transmission. Indeed, in the
absence ofmalaria elimination, near-term ITN scaleup efforts
may shift the demographic burden to older age-groups and
actually increase malaria-attributable deaths in adult pop-
ulations. This calls into question whether universal ITN cov-
erage alone can be relied on to eliminate malaria in a
hyperendemic country such as Ghana and echoes the
concerns raised by recent cluster-randomized trials of ITNs
and IRS in low-transmission settings which also question the
potential for ITNs, IRS, or a combination of those interven-
tions to achieve elimination.8
As countries work toward the Sustainable Development
Goals, sub-Saharan Africa is at the crossroads where poli-
cymakers increasingly strive for malaria elimination but
where present tools to combat malaria may not be sufficient
by themselves to achieve the objective. Where does this
leave us?
On the one hand, external factorswhich cannot be captured
in our model may influence the magnitude of effects that have
been presented in this study. For example, urbanization may
result in improvements in drainage and housing which affect
mosquito-breeding grounds and reduce human–vector con-
tact, and because these external factors may affect all ages
and be sustained, they may be less subject to the semi-
immunity effects which accompany scaling up of ITNs and
increase adult mortality.15 However, obtaining data to pa-
rameterize the extent to which multifaceted interventions
could achieve malaria elimination in Ghana goes beyond the
scope of this study. In the case ofmalaria in the United States,
for example, multiple direct and indirect factors have been
cited as contributing to successful eradication including a
long-term malaria education campaign, growth of health
FIGURE 7. 2015–2034 Public action: ITN scaling up (economic). (A) Insecticide-treated net scaleup to change in NPV GDP (billion US$; 2014
prices). (B) Insecticide-treated net scaleup to change in NPV GDP (% of NPV GDP). (C) Insecticide-treated net scaleup to change in NPV GDP per
capita (US$; 2014prices). (D) Insecticide-treated net scaleup to change inNPVGDPper capita (%ofNPVGDPper capita). ITN= insecticide-treated
net; NPV GDP = net present value of GDP (accounting for the future value of money). This figure appears in color at www.ajtmh.org.
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departments with focused malaria control, road and trans-
portation improvements, development of improved canal
systems, and large-scale use of larvicides followed by the
Extended Malaria Control Program, Malaria Eradication Pro-
gram, andmalaria surveillance.42 In addition to these complex
direct and indirect factors, external effects such as drug re-
sistance could hamper treatment, multiplying the health and
macroeconomic effects of mortality, and climate change has
also been cited as a potential confounder of the positive ef-
fects of socioeconomicdevelopment onmalaria elimination.43
However, although some research indicates that climate
change may provoke a net increase in population risk of
malaria, they also highlight that there are large uncertainties
and variations between models.44 By contrast, other spatial
studies have indicated that central climate change scenarios
have a negligible effect on malaria prevalence (PfPR2–10) by
2050.45 Given the complex nature of our integratedmodel, we
have not attempted to capture these effects.
In conclusion, our modeling does not support the hypoth-
esis that malaria elimination in a hyperendemic environment,
such as Ghana, can be achieved using current tools accom-
panied by economic growth. In short, the efficacy of our
present-day malaria control tools, in malaria-endemic areas,
depends on the degree of semi-immunity among the resident
populations in these areas. Research suggests that improved
vector control technologies are possible and, in their current
form, could provide affordable and more effective control in
areas with high population density.46 Future investment to
improve technology and/or delivery of these tools may ad-
vance progress toward elimination. Research to inform and
refine guidelines for vector control are ongoing and may en-
able the maximization of control and progress toward elimi-
nation within resource-limited environments.47 However,
regardless of how tools and implementation methods may
improve and change in coming years, previous experience
dictates that current levels of malaria control must be main-
tained and resurgence avoided, until malaria elimination is
accomplished.
Perhaps, the most viable route for accomplishing malaria
elimination is the development of new tools and technologies
that significantly reduce transmission and/or infection. For
example, the RTS,S pre-erythrocytic vaccine against Pf
malaria infections has been shown to provide 25–50% pro-
tection for infants over extended periods of time in clinical
trials, and pilot implementation of this vaccine is ongoing in
Ghana and two other pilot countries as part of routine immu-
nization services.48,49 Although it has been stated that vac-
cines which are currently under development and targeting
FIGURE 8. GDPper capita. (A) Uptake sensitivity of NPVGDP (growth scenarios) (billionUS$; 2014prices). (B) Uptake sensitivity of NPVGDP (ITN
scaleup) (billionUS$; 2014prices). (C) Uptake sensitivity of NPVGDPper capita (growth scenarios) (US$; 2014prices). (D) Uptake sensitivity of NPV
GDPper capita (ITN scaleup) (US$; 2014prices). ITN= insecticide-treated net; NPVGDP=net present value ofGDP (accounting for the future value
of money). This figure appears in color at www.ajtmh.org.
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parasitic diseases “cannot be compared to the well-known
highly efficacious vaccines of the childhood diseases caused
by bacteria and viruses,”50 partially efficacious vaccines
may show a significant alleviation of the disease burden and,
thus, illustrate the potential for future technological devel-
opments to facilitate rapid progress toward elimination be-
yond that which can be achieved by other existing control
measures.
Given the ineffectiveness of economicdevelopment and the
hard trade-offs presented by current vector control interven-
tions, future research and development of more effective
vector and disease control technologies and strategies for
application/dissemination should be pursued with intensity.
However, it is concerning that international donor support, in
the fight against malaria, has shown signs of stagnation, and
recent evidence suggests that although US$588 million (85%
of the estimated annual need) was spent on research and
development in 2016, research and development funding for
malaria vaccines and drugs declined in 2016 compared with
that in 2015.1 In addition, the Sustainable DevelopmentGoals,
though important, are more diffuse than the Millennium De-
velopment Goals and risk diluting financial support to the
health sector. Thus, reinforcement of current malaria control
measures and increased investment to develop efficacious
tools for malaria elimination are more urgent than ever.49 Our
research suggests that current interventions are unlikely to
achieve malaria elimination. This conclusion is supported by
the recent Lancet Commission which suggests that persis-
tenceofmalaria in 10 countries (includingGhana) is a barrier to
eradication and cannot be achieved under a business-as-
usual scenario or with current tools alone. However, the report
indicates that eradication is achievable by 2050 by “improving
management and operations and making better use of exist-
ing technologies, rolling out new technologies, and spending
moremoney” but, in contrast, failure to pursue this goal would
be “indefensible.”45 Unrelenting support for malaria control
alongside increased investment in elimination-targeted re-
search and development is therefore essential to maintain
current gains against malaria to avoid a resurgence in malaria
transmission andmalaria-attributable mortality and, ultimately,
to build on current progress to accomplish elimination.
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S1: ITN Uptake rates 
The household-specific estimates of coverage and ITN uptake rates were computed from a range of data 
sources. Household-specific coverage and uptake rates were derived from the 2014 Ghana Demographic 
and Health Survey (GHS 2015), while household-specific splits between private and public coverage 
rates were based on ‘public sector’ and ‘public campaign’ coverage estimates from the fourth round 
2012 MICS4 Multiple Indicator Cluster Survey (GSS 2012). A single average cost estimate for ITNs, 
computed as the weighted average of 'Public', 'Private' and 'Other' median costs from the 2012 MICS4 








(percent)   
Uptake rates 
(percent)   
Household private public/free 
   Low prevalence GAMA 16.3% 17.0%  49%  
Low prevalence Urban Coastal 14.2% 22.9% 
 
75% 
 Med prevalence Urban Coastal 14.2% 22.9% 
 
75% 
 HIgh prevalence Urban Coastal 14.2% 22.9% 
 
75% 
 Low prevalence Urban Forest 18.5% 24.1% 
 
70% 
 Med prevalence Urban Forest 18.5% 24.1% 
 
70% 
 HIgh prevalence Urban Forest 18.5% 24.1% 
 
70% 
 Low prevalence Urban Savannah 10.9% 20.1% 
 
78% 
 Med prevalence Urban Savannah 10.9% 20.1% 
 
78% 
 HIgh prevalence Urban Savannah 10.9% 20.1% 
 
78% 
 Low prevalence Rural Coastal 13.2% 30.0% 
 
128% 
 Med prevalence Rural Coastal 13.2% 30.0% 
 
128% 
 HIgh prevalence Rural Coastal 13.2% 30.0% 
 
128% 
 Low prevalence Rural Forest 18.1% 31.4% 
 
120% 
 Med prevalence Rural Forest 18.1% 31.4% 
 
120% 
 HIgh prevalence Rural Forest 18.1% 31.4% 
 
120% 
 Low prevalence Rural Savannah 9.7% 26.2% 
 
134% 
 Med prevalence Rural Savannah 9.7% 26.2% 
 
134% 






GHS (Ghana Health Service). 2015. Ghana Demographic and Health Survey. Ghana Statistical Service and 
Ghana Health Service, Accra. 
 
GSS (Ghana Statistical Services). 2012. Multiple Indicator Cluster Survey, round 4 (MICS4). Ghana 
Statistical Services. Accra. 
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S2: Sensitivity of Uptake Results (GDP) 
 
Growth Scenarios 
∆NPV GDP impacts (bn USD): 
   
 
+2% growth +1% growth baseline -1% growth -2% growth 
+50% uptake rate 6.99 5.95 5.00 4.13 3.35 
baseline 7.20 6.12 5.14 4.25 3.45 
-50% uptake rate 7.29 6.18 5.19 4.29 3.48 
∆NPV GDP per capita impacts (USD): 
  
 
+2% growth +1% growth baseline -1% growth -2% growth 
+50% uptake rate 8.49 7.12 5.87 4.72 3.68 
baseline 8.83 7.40 6.10 4.91 3.84 




∆NPV GDP impacts (bn USD): 
   
 
+5%-point  +10%-point  +15%-point  +20%-point  +25%-point  
+50% uptake rate -0.28 -0.56 -0.83 -1.09 -1.35 
baseline -0.31 -0.63 -0.94 -1.25 -1.56 
-50% uptake rate -0.34 -0.68 -1.02 -1.36 -1.70 
∆NPV GDP per capita impacts (USD): 
  
 
+5%-point  +10%-point  +15%-point  +20%-point  +25%-point  
+50% uptake rate -0.36 -0.71 -1.05 -1.38 -1.71 
baseline -0.39 -0.79 -1.19 -1.58 -1.98 
-50% uptake rate -0.44 -0.87 -1.31 -1.75 -2.19 
 
 
 
